Investigating Shared Genetic Basis Across Tourette Syndrome and Comorbid Neurodevelopmental Disorders Along the Impulsivity-Compulsivity Spectrum.


Journal

Biological psychiatry
ISSN: 1873-2402
Titre abrégé: Biol Psychiatry
Pays: United States
ID NLM: 0213264

Informations de publication

Date de publication:
01 09 2021
Historique:
received: 09 03 2020
revised: 21 12 2020
accepted: 21 12 2020
pubmed: 15 3 2021
medline: 28 9 2021
entrez: 14 3 2021
Statut: ppublish

Résumé

Tourette syndrome (TS) is often found comorbid with other neurodevelopmental disorders across the impulsivity-compulsivity spectrum, with attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and obsessive-compulsive disorder (OCD) as most prevalent. This points to the possibility of a common etiological thread along an impulsivity-compulsivity continuum. Investigating the shared genetic basis across TS, ADHD, ASD, and OCD, we undertook an evaluation of cross-disorder genetic architecture and systematic meta-analysis, integrating summary statistics from the latest genome-wide association studies (93,294 individuals, 6,788,510 markers). As previously identified, a common unifying factor connects TS, ADHD, and ASD, while TS and OCD show the highest genetic correlation in pairwise testing among these disorders. Thanks to a more homogeneous set of disorders and a targeted approach that is guided by genetic correlations, we were able to identify multiple novel hits and regions that seem to play a pleiotropic role for the specific disorders analyzed here and could not be identified through previous studies. In the TS-ADHD-ASD genome-wide association study single nucleotide polymorphism-based and gene-based meta-analysis, we uncovered 13 genome-wide significant regions that host single nucleotide polymorphisms with a high posterior probability for association with all three studied disorders (m-value > 0.9), 11 of which were not identified in previous cross-disorder analysis. In contrast, we also identified two additional pleiotropic regions in the TS-OCD meta-analysis. Through conditional analysis, we highlighted genes and genetic regions that play a specific role in a TS-ADHD-ASD genetic factor versus TS-OCD. Cross-disorder tissue specificity analysis implicated the hypothalamus-pituitary-adrenal gland axis in TS-ADHD-ASD. Our work underlines the value of redefining the framework for research across traditional diagnostic categories.

Sections du résumé

BACKGROUND
Tourette syndrome (TS) is often found comorbid with other neurodevelopmental disorders across the impulsivity-compulsivity spectrum, with attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and obsessive-compulsive disorder (OCD) as most prevalent. This points to the possibility of a common etiological thread along an impulsivity-compulsivity continuum.
METHODS
Investigating the shared genetic basis across TS, ADHD, ASD, and OCD, we undertook an evaluation of cross-disorder genetic architecture and systematic meta-analysis, integrating summary statistics from the latest genome-wide association studies (93,294 individuals, 6,788,510 markers).
RESULTS
As previously identified, a common unifying factor connects TS, ADHD, and ASD, while TS and OCD show the highest genetic correlation in pairwise testing among these disorders. Thanks to a more homogeneous set of disorders and a targeted approach that is guided by genetic correlations, we were able to identify multiple novel hits and regions that seem to play a pleiotropic role for the specific disorders analyzed here and could not be identified through previous studies. In the TS-ADHD-ASD genome-wide association study single nucleotide polymorphism-based and gene-based meta-analysis, we uncovered 13 genome-wide significant regions that host single nucleotide polymorphisms with a high posterior probability for association with all three studied disorders (m-value > 0.9), 11 of which were not identified in previous cross-disorder analysis. In contrast, we also identified two additional pleiotropic regions in the TS-OCD meta-analysis. Through conditional analysis, we highlighted genes and genetic regions that play a specific role in a TS-ADHD-ASD genetic factor versus TS-OCD. Cross-disorder tissue specificity analysis implicated the hypothalamus-pituitary-adrenal gland axis in TS-ADHD-ASD.
CONCLUSIONS
Our work underlines the value of redefining the framework for research across traditional diagnostic categories.

Identifiants

pubmed: 33714545
pii: S0006-3223(21)00038-X
doi: 10.1016/j.biopsych.2020.12.028
pmc: PMC9152955
mid: NIHMS1661062
pii:
doi:

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

317-327

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH101519
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH119243
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS105746
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH109536
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Références

Nat Rev Dis Primers. 2017 Feb 02;3:16097
pubmed: 28150698
Genome Biol. 2004;5(3):R13
pubmed: 15003116
PLoS Comput Biol. 2015 Apr 17;11(4):e1004219
pubmed: 25885710
Int Rev Neurobiol. 2013;112:239-79
pubmed: 24295624
Nat Commun. 2018 Jan 15;9(1):224
pubmed: 29335400
Am J Psychiatry. 2019 Mar 1;176(3):217-227
pubmed: 30818990
Nat Rev Genet. 2017 Jun;18(6):362-376
pubmed: 28260791
Med Hypotheses. 2010 May;74(5):862-7
pubmed: 20022434
J Neurol Sci. 2016 Jan 15;360:94-7
pubmed: 26723981
Am J Med Genet B Neuropsychiatr Genet. 2014 Dec;165B(8):619-26
pubmed: 25228354
Science. 2018 Jun 22;360(6395):
pubmed: 29930110
PLoS One. 2013 Sep 19;8(9):e75006
pubmed: 24069373
Nat Genet. 2019 Mar;51(3):431-444
pubmed: 30804558
Biol Psychiatry. 2010 Sep 1;68(5):484-90
pubmed: 20497900
Nat Genet. 2016 Sep;48(9):1031-6
pubmed: 27479909
Nat Genet. 2013 Sep;45(9):984-94
pubmed: 23933821
Cell. 2019 Dec 12;179(7):1469-1482.e11
pubmed: 31835028
Hum Genet. 2020 Feb;139(2):185-198
pubmed: 31813014
Nat Rev Neurosci. 2015 Mar;16(3):126-32
pubmed: 25669742
Nat Genet. 2015 Nov;47(11):1236-41
pubmed: 26414676
Am J Hum Genet. 2012 May 4;90(5):821-35
pubmed: 22560090
Psychiatr Clin North Am. 2014 Sep;37(3):319-35
pubmed: 25150565
Nat Genet. 2019 Jan;51(1):63-75
pubmed: 30478444
PLoS Comput Biol. 2017 Mar 30;13(3):e1005395
pubmed: 28358814
Int J Psychiatry Clin Pract. 2005;9(2):79-86
pubmed: 24930787
Mol Psychiatry. 2018 May;23(5):1181-1188
pubmed: 28761083
Nucleic Acids Res. 2010 Nov;38(20):6895-905
pubmed: 20624818
Neuropsychopharmacology. 2005 Sep;30(9):1735-40
pubmed: 15841109
Nature. 2017 Oct 11;550(7675):204-213
pubmed: 29022597
Psychoneuroendocrinology. 2009 Oct;34(9):1272-83
pubmed: 19406581
J Cell Biochem. 2019 Apr;120(4):4851-4862
pubmed: 30623482
Transl Psychiatry. 2014 Mar 18;4:e373
pubmed: 24643164
Nat Rev Neurosci. 2008 Dec;9(12):899-909
pubmed: 19002190
J Psychosom Res. 2002 Oct;53(4):865-71
pubmed: 12377295
JAMA Psychiatry. 2019 Mar 1;76(3):280-289
pubmed: 30566181
Nat Commun. 2017 Nov 28;8(1):1826
pubmed: 29184056
Nat Genet. 2015 Nov;47(11):1228-35
pubmed: 26414678
Eur Arch Psychiatry Clin Neurosci. 2018 Apr;268(3):301-316
pubmed: 28555406
Hippocampus. 2017 Mar;27(3):235-248
pubmed: 27935149
Lancet. 2013 Apr 20;381(9875):1371-1379
pubmed: 23453885
Pharmacol Biochem Behav. 2012 Feb;100(4):841-9
pubmed: 21756930
Psychoneuroendocrinology. 2008 Jul;33(6):810-20
pubmed: 18487023
JAMA Psychiatry. 2015 Apr;72(4):325-33
pubmed: 25671412
Eur Child Adolesc Psychiatry. 2009 Sep;18(9):543-53
pubmed: 19294447
Epidemiol Psychiatr Sci. 2014 Sep;23(3):235-8
pubmed: 24816251
Int Rev Neurobiol. 2013;112:155-77
pubmed: 24295621
J Am Acad Child Adolesc Psychiatry. 2000 Nov;39(11):1438-45
pubmed: 11068900
J Am Acad Child Adolesc Psychiatry. 2014 Jul;53(7):780-9.e11
pubmed: 24954827
Psychoneuroendocrinology. 2016 Dec;74:203-211
pubmed: 27665080
Nat Rev Dis Primers. 2015 Aug 06;1:15020
pubmed: 27189265
Child Adolesc Psychiatry Ment Health. 2017 Dec 4;11:59
pubmed: 29225671
Mol Autism. 2017 May 22;8:21
pubmed: 28540026
Ann Neurol. 2005 Dec;58(6):909-19
pubmed: 16315276
Nat Hum Behav. 2019 May;3(5):513-525
pubmed: 30962613
PLoS Genet. 2012;8(3):e1002555
pubmed: 22396665

Auteurs

Zhiyu Yang (Z)

Department of Biological Sciences, Purdue University, West Lafayette, Indiana.

Hanrui Wu (H)

Department of Biological Sciences, Purdue University, West Lafayette, Indiana.

Phil H Lee (PH)

Psychiatric and Neurodevelopmental Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.

Fotis Tsetsos (F)

Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupoli, Greece.

Lea K Davis (LK)

Division of Genetic Medicine, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, Tennessee.

Dongmei Yu (D)

Psychiatric and Neurodevelopmental Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.

Sang Hong Lee (SH)

Queensland Brain Institute, University of Queensland, Brisbane, Queensland; Australian Centre for Precision Health, University of South Australia Cancer Research Institute, University of South Australia, Adelaide, South Australia.

Søren Dalsgaard (S)

Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark; National Centre for Register-based Research, Aarhus University, Aarhus, Denmark; Department of Child and Adolescent Psychiatry, Hospital of Telemark, Kragerø, Norway.

Jan Haavik (J)

K.G. Jebsen Centre for Neuropsychiatric Disorders, Department of Biomedicine, University of Bergen, Bergen, Norway; Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.

Csaba Barta (C)

Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary.

Tetyana Zayats (T)

Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; K.G. Jebsen Centre for Neuropsychiatric Disorders, Department of Biomedicine, University of Bergen, Bergen, Norway.

Valsamma Eapen (V)

Academic Unit of Child Psychiatry South West Sydney, School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia.

Naomi R Wray (NR)

Queensland Brain Institute, University of Queensland, Brisbane, Queensland; Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland.

Bernie Devlin (B)

Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Mark Daly (M)

Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Stanley Center for Psychiatric Research, Broad Institute, Cambridge, Massachusetts.

Benjamin Neale (B)

Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Stanley Center for Psychiatric Research, Broad Institute, Cambridge, Massachusetts; Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts.

Anders D Børglum (AD)

Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark; Department of Biomedicine - Human Genetics, Aarhus University, Aarhus, Denmark; Center for Integrative Sequencing (iSEQ), Aarhus University, Aarhus, Denmark; Center for Genomics and Personalized Medicine, Aarhus, Denmark.

James J Crowley (JJ)

Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Jeremiah Scharf (J)

Psychiatric and Neurodevelopmental Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.

Carol A Mathews (CA)

Department of Psychiatry, University of Florida, Gainesville, Florida; Department of Genetics Institute, University of Florida, Gainesville, Florida.

Stephen V Faraone (SV)

Departmentof Psychiatry, SUNY Upstate Medical University, Syracuse, New York; Departmentof Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, New York.

Barbara Franke (B)

Department of Human Genetics, Radboud University Medical Center, Radboud University, Nijmegen, The Netherlands; Department of Psychiatry, Radboud University Medical Center, Radboud University, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.

Manuel Mattheisen (M)

Department of Biomedicine, Aarhus University, Aarhus, Denmark; Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital Wuerzburg, Wuerzburg, Germany; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden.

Jordan W Smoller (JW)

Psychiatric and Neurodevelopmental Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts; Stanley Center for Psychiatric Research, Broad Institute, Cambridge, Massachusetts.

Peristera Paschou (P)

Department of Biological Sciences, Purdue University, West Lafayette, Indiana. Electronic address: ppaschou@purdue.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH